Showing 341-350 of 1043 results for "".
Persistent Idiopathic Isolated Hypoglossal Nerve Palsy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/persistent-idiopathic-isolated-hypoglossal-nerve-palsy/30188/Could this rare condition be related to vascular compression?Vascular Cognitive Impairment, Part 2
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/vascular-cognitive-impairment-part-2/30582/Cognitive impairment after acute stroke is likely under-appreciated despite its impact.Epilepsy Essentials: Seizure Disorders and Commercial Motor Vehicle Operators
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-seizure-disorders-and-commercial-motor-vehicle-operators/30858/Clinical neurologists should be familiar with regulations regarding commercial drivers' qualifications to drive and the role of third party examiners.Special Report: 2024 Neurology Drug & Device Approvals
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/special-report-2024-neurology-drug-device-approvals/33149/A quick reference for the drugs and devices for neurologic conditions that received approval or clearance notice from the Food and Drug Administration (FDA) last year.Hometown Highlights: Congenital Myasthenic Syndromes
https://practicalneurology.com/diseases-diagnoses/neuromuscular/hometown-highlights-congenital-myasthenic-syndromes/30130/With careful diagnosis, treatment can improve symptoms of congenital myasthenic syndromes.Stroke Research Continues to Support Rapid Assessment, Personalized Treatment Approaches
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-research-continues-to-support-rapid-assessment-personalized-treatment-approaches/30603/Several key studies were published this year, and results of a stem cell study may be on the horizon.Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Fluid Biomarkers in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fluid-biomarkers-in-multiple-sclerosis/36255/Fluid biomarkers may allow for improvement in diagnosis, prognostication, and monitoring of disease activity and treatment response in multiple sclerosis while reducing reliance on imaging.Neuromuscular Notes: Autoantibody Evaluations for Peripheral Neuropathies
https://practicalneurology.com/diseases-diagnoses/headache-pain/neuromuscular-notes-autoantibody-evaluations-for-peripheral-neuropathies/31857/Phenotype and nerve conduction can guide the search for autoantibodies in peripheral neuropathy.- Will the Medical Liability Crisis Hammer Your Practice?https://practicalneurology.com/archives/2005-june/PN0605malpractice-pdf/31441/Medical Malpractice Reform: Navigating the Ongoing Liability CrisisMedical malpractice reform remains a critical yet contentious issue within the healthcare sector, as highlighted in the June 2005 issue of *Practical Neurology*. Despite sustained advocacy by physicians, national progress on liabilit